GlassScriptPhysician profile
Dylan Golomb
NPI 1578066817
$1,669.84
in general payments reported to CMS, 2019-2025
8 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $126 · 2021: $234 · 2022: $670 · 2023: $266 · 2024: $109 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $514.13 | 2021-2024 | |
| Teva Pharmaceuticals USA, INC. | $419.90 | 2022-2023 | Austedo Xr |
| Neurocrine Biosciences, INC. | $152.82 | 2022 | |
| Jazz Pharmaceuticals INC. | $147.71 | 2025 | |
| Allergan, INC. | $125.94 | 2020 | |
| Corium, LLC | $124.93 | 2022 | |
| Galderma Laboratories, L.P. | $117.72 | 2025 | Nemluvio |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $66.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Golomb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.